ID   NADE_HUMAN              Reviewed;         706 AA.
AC   Q6IA69; B3KUU4; Q86SN2; Q9HA25; Q9NVM8;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 3.
DT   10-MAY-2017, entry version 117.
DE   RecName: Full=Glutamine-dependent NAD(+) synthetase;
DE            EC=6.3.5.1;
DE   AltName: Full=NAD(+) synthase [glutamine-hydrolyzing];
DE   AltName: Full=NAD(+) synthetase;
GN   Name=NADSYN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBUNIT, MUTAGENESIS OF
RP   CYS-175, BIOPHYSICOCHEMICAL PROPERTIES, AND VARIANT HIS-204.
RC   TISSUE=Brain;
RX   PubMed=12547821; DOI=10.1074/jbc.M209203200;
RA   Hara N., Yamada K., Terashima M., Osago H., Shimoyama M., Tsuchiya M.;
RT   "Molecular identification of human glutamine- and ammonia-dependent
RT   NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine
RT   dependency.";
RL   J. Biol. Chem. 278:10914-10921(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS LEU-74 AND HIS-204.
RC   TISSUE=Mammary gland, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   LEU-74 AND HIS-204.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   LEU-74 AND HIS-204.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- CATALYTIC ACTIVITY: ATP + deamido-NAD(+) + L-glutamine + H(2)O =
CC       AMP + diphosphate + NAD(+) + L-glutamate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.49 mM for deamido-NAD(+) {ECO:0000269|PubMed:12547821};
CC         KM=0.089 mM for ATP {ECO:0000269|PubMed:12547821};
CC         KM=1.44 mM for glutamine {ECO:0000269|PubMed:12547821};
CC         KM=13.1 mM for ammonium {ECO:0000269|PubMed:12547821};
CC         Vmax=0.99 nmol/min/ug enzyme deamido-NAD(+)
CC         {ECO:0000269|PubMed:12547821};
CC         Vmax=0.61 nmol/min/ug enzyme ATP {ECO:0000269|PubMed:12547821};
CC         Vmax=0.70 nmol/min/ug enzyme glutamine
CC         {ECO:0000269|PubMed:12547821};
CC         Vmax=1.04 nmol/min/ug enzyme ammonium
CC         {ECO:0000269|PubMed:12547821};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from
CC       deamido-NAD(+) (L-Gln route): step 1/1.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:12547821}.
CC   -!- INTERACTION:
CC       Q9H614:-; NbExp=3; IntAct=EBI-748610, EBI-10249899;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6IA69-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6IA69-2; Sequence=VSP_056585, VSP_056586;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NAD
CC       synthetase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB091316; BAC65148.1; -; mRNA.
DR   EMBL; AK001493; BAA91722.1; -; mRNA.
DR   EMBL; AK022436; BAB14034.1; -; mRNA.
DR   EMBL; AK097946; BAG53556.1; -; mRNA.
DR   EMBL; CR457286; CAG33567.1; -; mRNA.
DR   EMBL; AP000867; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002387; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74792.1; -; Genomic_DNA.
DR   EMBL; BC003638; AAH03638.1; -; mRNA.
DR   EMBL; BC003666; AAH03666.1; -; mRNA.
DR   CCDS; CCDS8201.1; -. [Q6IA69-1]
DR   RefSeq; NP_060631.2; NM_018161.4. [Q6IA69-1]
DR   UniGene; Hs.556986; -.
DR   ProteinModelPortal; Q6IA69; -.
DR   BioGrid; 120488; 7.
DR   IntAct; Q6IA69; 15.
DR   MINT; MINT-1450170; -.
DR   STRING; 9606.ENSP00000326424; -.
DR   BindingDB; Q6IA69; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   iPTMnet; Q6IA69; -.
DR   PhosphoSitePlus; Q6IA69; -.
DR   BioMuta; NADSYN1; -.
DR   DMDM; 257051045; -.
DR   EPD; Q6IA69; -.
DR   MaxQB; Q6IA69; -.
DR   PaxDb; Q6IA69; -.
DR   PeptideAtlas; Q6IA69; -.
DR   PRIDE; Q6IA69; -.
DR   Ensembl; ENST00000319023; ENSP00000326424; ENSG00000172890. [Q6IA69-1]
DR   GeneID; 55191; -.
DR   KEGG; hsa:55191; -.
DR   UCSC; uc001oqn.4; human. [Q6IA69-1]
DR   CTD; 55191; -.
DR   DisGeNET; 55191; -.
DR   GeneCards; NADSYN1; -.
DR   H-InvDB; HIX0035837; -.
DR   HGNC; HGNC:29832; NADSYN1.
DR   HPA; CAB017798; -.
DR   HPA; HPA038523; -.
DR   HPA; HPA038524; -.
DR   MIM; 608285; gene.
DR   neXtProt; NX_Q6IA69; -.
DR   OpenTargets; ENSG00000172890; -.
DR   PharmGKB; PA142671299; -.
DR   eggNOG; KOG2303; Eukaryota.
DR   eggNOG; COG0171; LUCA.
DR   eggNOG; COG0388; LUCA.
DR   GeneTree; ENSGT00390000010152; -.
DR   HOGENOM; HOG000160137; -.
DR   HOVERGEN; HBG082007; -.
DR   InParanoid; Q6IA69; -.
DR   KO; K01950; -.
DR   OMA; SCHEDLL; -.
DR   OrthoDB; EOG091G022X; -.
DR   PhylomeDB; Q6IA69; -.
DR   TreeFam; TF351426; -.
DR   BioCyc; MetaCyc:HS10587-MONOMER; -.
DR   BRENDA; 6.3.5.1; 2681.
DR   Reactome; R-HSA-196807; Nicotinate metabolism.
DR   UniPathway; UPA00253; UER00334.
DR   ChiTaRS; NADSYN1; human.
DR   GeneWiki; NADSYN1; -.
DR   GenomeRNAi; 55191; -.
DR   PRO; PR:Q6IA69; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172890; -.
DR   CleanEx; HS_NADSYN1; -.
DR   ExpressionAtlas; Q6IA69; baseline and differential.
DR   Genevisible; Q6IA69; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004359; F:glutaminase activity; IBA:GO_Central.
DR   GO; GO:0003952; F:NAD+ synthase (glutamine-hydrolyzing) activity; IBA:GO_Central.
DR   GO; GO:0009435; P:NAD biosynthetic process; IBA:GO_Central.
DR   GO; GO:0019674; P:NAD metabolic process; TAS:Reactome.
DR   CDD; cd00553; NAD_synthase; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.60.110.10; -; 1.
DR   HAMAP; MF_02090; NadE_glutamine_dep; 1.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   InterPro; IPR014445; Gln-dep_NAD_synthase.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR003694; NAD_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   PANTHER; PTHR23090; PTHR23090; 1.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   PIRSF; PIRSF006630; NADS_GAT; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   TIGRFAMs; TIGR00552; nadE; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Ligase; NAD;
KW   Nucleotide-binding; Polymorphism; Reference proteome.
FT   CHAIN         1    706       Glutamine-dependent NAD(+) synthetase.
FT                                /FTId=PRO_0000237577.
FT   DOMAIN        5    299       CN hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   NP_BIND     355    362       ATP. {ECO:0000250}.
FT   REGION      325    706       Ligase. {ECO:0000250}.
FT   ACT_SITE     45     45       Proton acceptor; for glutaminase
FT                                activity. {ECO:0000250|UniProtKB:P9WJJ3}.
FT   ACT_SITE    114    114       For glutaminase activity.
FT                                {ECO:0000250|UniProtKB:P9WJJ3}.
FT   ACT_SITE    175    175       Nucleophile; for glutaminase activity.
FT                                {ECO:0000250|UniProtKB:P9WJJ3}.
FT   ACT_SITE    357    357       {ECO:0000250}.
FT   VAR_SEQ       1      6       MGRKVT -> MGISGQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056585.
FT   VAR_SEQ       7    266       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056586.
FT   VARIANT      74     74       V -> L (in dbSNP:rs2276360).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_026497.
FT   VARIANT     204    204       Q -> H (in dbSNP:rs7950441).
FT                                {ECO:0000269|PubMed:12547821,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_058703.
FT   VARIANT     297    297       P -> L (in dbSNP:rs7121106).
FT                                /FTId=VAR_056204.
FT   VARIANT     591    591       M -> I (in dbSNP:rs35007971).
FT                                /FTId=VAR_056205.
FT   VARIANT     704    704       G -> S (in dbSNP:rs12282060).
FT                                /FTId=VAR_056206.
FT   MUTAGEN     175    175       C->S: Eliminates glutamine-dependent NAD
FT                                synthetase activity with the ammonia-
FT                                dependent activity intact.
FT                                {ECO:0000269|PubMed:12547821}.
FT   CONFLICT    102    102       I -> V (in Ref. 1; BAC65148).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       R -> H (in Ref. 3; CAG33567).
FT                                {ECO:0000305}.
FT   CONFLICT    623    623       W -> R (in Ref. 1; BAC65148).
FT                                {ECO:0000305}.
SQ   SEQUENCE   706 AA;  79285 MW;  9788B060F3A1D13B CRC64;
     MGRKVTVATC ALNQWALDFE GNLQRILKSI EIAKNRGARY RLGPELEICG YGCWDHYYES
     DTLLHSFQVL AALVESPVTQ DIICDVGMPV MHRNVRYNCR VIFLNRKILL IRPKMALANE
     GNYRELRWFT PWSRSRHTEE YFLPRMIQDL TKQETVPFGD AVLVTWDTCI GSEICEELWT
     PHSPHIDMGL DGVEIITNAS GSHQVLRKAN TRVDLVTMVT SKNGGIYLLA NQKGCDGDRL
     YYDGCAMIAM NGSVFAQGSQ FSLDDVEVLT ATLDLEDVRS YRAEISSRNL AASRASPYPR
     VKVDFALSCH EDLLAPISEP IEWKYHSPEE EISLGPACWL WDFLRRSQQA GFLLPLSGGV
     DSAATACLIY SMCCQVCEAV RSGNEEVLAD VRTIVNQISY TPQDPRDLCG RILTTCYMAS
     KNSSQETCTR ARELAQQIGS HHISLNIDPA VKAVMGIFSL VTGKSPLFAA HGGSSRENLA
     LQNVQARIRM VLAYLFAQLS LWSRGVHGGL LVLGSANVDE SLLGYLTKYD CSSADINPIG
     GISKTDLRAF VQFCIQRFQL PALQSILLAP ATAELEPLAD GQVSQTDEED MGMTYAELSV
     YGKLRKVAKM GPYSMFCKLL GMWRHICTPR QVADKVKRFF SKYSMNRHKM TTLTPAYHAE
     NYSPEDNRFD LRPFLYNTSW PWQFRCIENQ VLQLERAEPQ SLDGVD
//
